Home » Topics » BioWorld Science

BioWorld Science
RSS

Identification of a diagnostic gene signature in Kawasaki disease

Sep. 20, 2018

Iterum announces the initiation of SURE 2 and SURE 3 phase III studies for sulopenem

Sep. 20, 2018

White matter targeting improves TBI outcomes

Sep. 20, 2018

Viva VIVO

Sep. 20, 2018

Zinc fingers go where CRISPR can't

Sep. 20, 2018

Chemical changes make arylomycins great against Gram-negatives

Sep. 20, 2018

Alector initiates phase I study of AL-001 for frontotemporal dementia

Sep. 19, 2018

Identification of P. falciparum ER translocation interactome for protein export to the erythrocyte

Sep. 19, 2018

Design of potentially efficacious and safe small interfering RNAs against Zika virus infection

Sep. 19, 2018

ICU patients without Enterobacteriaceae infection should not receive carbapenems

Sep. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...